Australia: European Developments: To Regulate Or Not To Regulate - That Is The Question?

Last Updated: 12 October 2009
Article by Amanda Turnill

Key Points:
Australian manufacturers and suppliers who export products to the EU should keep in mind that reforms across a number of fronts could have an impact on their business.

"We must have more competition and less red tape in pharmaceuticals. The sector is too important to the health and finances of Europe's citizens and governments to accept anything less than the best. The inquiry has told us what is wrong with the sector, and now it is time to act. When it comes to generic entry, every week and month of delay costs money to patients and taxpayers. We will not hesitate to apply the antitrust rules where such delays result from anticompetitive practices. The first antitrust investigations are already underway, and regulatory adjustments are expected to follow dealing with a range of problems in the sector".

This statement from the European Commissioner for Competition, Neelie Kroes, reflects the European Commission's (EC) findings from the recent inquiry into the pharmaceutical sector under EC antitrust law. This is one of a number of critical developments in Europe which highlight a trend towards increasing regulation of the industry, and call for regulatory reform on a number of fronts. Here we examine those recent developments, and their potential impact for Australian pharma.

Antitrust regulation

The EC's antitrust inquiry into the pharmaceutical sector began in earnest back in January 2008 after concerns were raised by the EC that it had observed both:

  • a decline in the introduction of novel medicines in the EU; and
  • notable delays for generic products to come onto the market.

A preliminary report was first published by the EC on 28 November 2008 and, following public consultation, the final report on competition in the pharmaceutical sector was adopted on 8 July 2009.

The report found that competition in the pharmaceutical sector was not working as effectively as it should, with both delays to market entry of generic medicines, and a decline in innovation with less new medicines reaching the market each year.

This position was considered unacceptable by the EC which has proposed various remedial steps including:

  • the application of increased scrutiny under EC competition law to the sector and bringing specific cases where appropriate; and
  • the creation of a single community patent and specialised patent litigation system to reduce administrative problems for companies.

Further, the EC is urging Member States to:

  • accelerate approvals of generic medicines and to take action against any steps designed to prevent generic medicines from entering the market; and
  • streamline trials that test the "added value" of novel medicines.

These developments are significant for Australian companies supplying generic medicines in the European Union (EU). The potential for the reduction of barriers may bring new opportunities.

Outside of the inquiry, specific enforcement action is already underway in a number of cases. Highly publicised "dawn raids" were carried out at a number of companies in different member states suggesting a trend towards increased anti competitive regulation. Only time will tell if this trend continues.

Collective redress - Europe

In addition to the potential for change in the competition arena, the issue of collective redress still remains on the reform agenda in Europe.

In the April 2008 edition of Insights we examined the possible move towards a collective redress system in the EU. We noted that the EC had been examining the problems faced by consumers when attempting to obtain redress for a breach of their rights and that reform of the redress system has significant implications for the business community.

The EC expressed the view that individuals often refrained from bringing individual claims to court due to the costs involved and the difficulty met in sustaining such claims. Further, with only 13 member states providing for collective redress, difficulties arise for consumers attempting to take such action.

Since then, in November 2008, the EC (through the Directorate General for Health and Consumer Protection (DG SANCO)) published a Green Paper on Collective Redress in order to address the problems faced by consumers in the EU with the stated intention to:

assess the current state of redress mechanisms, in particular in cases where many consumers are likely to be affected by the same legal infringement, and to provide options to close any gaps to effective redress identified in such cases.

The Green Paper sets out four options when considering reform:

  • taking no immediate action;
  • encouraging cooperation between EU Member States to extend national collective redress systems to consumers from other Member States (without a collective redress mechanism available to them);
  • introducing policy instruments to strengthen consumer redress; and
  • introducing binding or non binding measures for collective redress judicial procedures that would operate in all Member States, including the potential for an opt-out form of collective redress mechanism.

Following publication of the Green Paper, the EC invited comments from stakeholders, consumers and interested parties on the impact of the proposed options in the Green Paper. Those specific comments and feedback from stakeholders (which are now available) go beyond the scope of this article.

Significantly, DG SANCO also published a consultation paper to follow up on the Green Paper. This contained an analysis of the options in the light of replies to the Green Paper and introduced additional options addressing the question of redress, for example, "an EU-wide judicial collective redress mechanism including collective ADR". Relevantly, this paper saw a shift in focus by DG SANCO from the suggestion in the Green Paper of an opt-out form of collective redress system, to more of a test case style procedure in the context of the judicial mechanism.

A summary of the contributions to DG SANCO's consultation paper has since been published, based on responses received by 24 July 2009. Broadly speaking, industry representatives stated that there was insufficient evidence to demonstrate the scale of the problem within Europe, whereas consumer representatives tended to highlight the cross-border difficulties that would arise when seeking to join a collective action across member states. Of those who responded to the paper, most consumers, legal practitioners and one EU Member State supported community intervention. At the other end of the spectrum, industry representatives who responded were content with maintaining the status quo.

Division over the most appropriate mechanism will continue to fuel the debate in Europe about how to ensure that mass consumer claims can be effectively managed. We await further action from the EC. In the meantime, Australian manufacturers and suppliers which export products to the EU should keep in mind that reform could have an impact on litigation risk in Europe.

We will continue to monitor European developments and provide further updates in Insights.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions